Serial changes of lung morphology and biochemical profiles in a rat model of bronchopulmonary dysplasia induced by intra-amniotic lipopolysaccharide and postnatal hyperoxia

J Perinat Med. 2010 Nov;38(6):675-81. doi: 10.1515/jpm.2010.091. Epub 2010 Aug 13.

Abstract

Aim: to investigate serial changes of lung morphology and biochemical profiles in a rat model of bronchopulmonary dysplasia (BPD) induced by intra-amniotic lipopolysaccharide (LPS) administration and postnatal hyperoxia (85%).

Methods: we evaluated histological changes of the lungs and compared the levels of interleukin-6 (IL-6), vascular endothelial growth factor (VEGF), and protein carbonyl in lung tissue on days 1, 7, and 14 after birth in a rat model of BPD.

Results: the inhibition of alveolarization was sustained in the LPS plus hyperoxia group from day 7 to 14, whereas alveolarization resumed in the hyperoxia group after oxygen exposure was withdrawn at day 7. Administration of LPS alone did not adversely affect lung morphometry. IL-6 levels showed transient overexpression at day 1 in the LPS-treated groups, but decreased at days 7 and 14. VEGF protein levels were elevated in the LPS-treated groups, but not in the hyper-oxia and control groups at days 1, 7, and 14. Exposure to hyperoxia affected protein carbonyl levels in the hyperoxia group at days 7 and 14.

Conclusion: lung injury induced by intra-amniotic inflammation and postnatal hyperoxia may be due to inhibition of alveolarization without recovery even after withdrawal of oxygen.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Newborn
  • Bronchopulmonary Dysplasia / chemically induced
  • Bronchopulmonary Dysplasia / metabolism
  • Bronchopulmonary Dysplasia / pathology*
  • Disease Models, Animal
  • Female
  • Histocytochemistry
  • Humans
  • Hyperoxia / pathology
  • Infant, Newborn
  • Interleukin-6 / metabolism
  • Lipopolysaccharides / pharmacology
  • Male
  • Pregnancy
  • Protein Carbonylation
  • Pulmonary Alveoli / drug effects*
  • Pulmonary Alveoli / metabolism
  • Pulmonary Alveoli / ultrastructure
  • Rats
  • Rats, Sprague-Dawley
  • Survival Analysis
  • Vascular Endothelial Growth Factor A / metabolism

Substances

  • Interleukin-6
  • Lipopolysaccharides
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A